nach oben

Head and Neck Pathology

Erschienen in:

21.03.2022 | Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Oropharynx and Nasopharynx

verfasst von: Cécile Badoual

Erschienen in: Head and Neck Pathology | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

The new WHO classification of head and neck tumors provides a comprehensive overview of lesions by summarizing their clinical, epidemiological, histological, immunohistochemical, molecular and genetic features. The chapters related to the description of oropharyngeal and nasopharyngeal lesions have thus been largely modified.

El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. 4th ed. Lyon: International Agency for Research on Cancer; 2017.

WHO Classification of Tumours Editorial Board. WHO classification of tumours series. Head and neck tumours. 5th ed., vol. 9. Lyon: International Agency for Research on Cancer; 2022.

Fossum CC, Chintakuntlawar AV, Price DL, Garcia JJ. Characterization of the oropharynx: anatomy, histology, immunology, squamous cell carcinoma and surgical resection. Histopathology. 2017;70:1021–9. https://doi.org/10.1111/his.13140.CrossRefPubMed

Kardon DE, Wenig BM, Heffner DK, Thompson LDR. Tonsillar lymphangiomatous polyps: a clinicopathologic series of 26 cases. Mod Pathol. 2000;13:1128–33.PubMed

Barreto I, Costa AF, Martins MT, Furuse C, de Araújo VC, Altemani A. Immunohistochemical study of stromal and vascular components of tonsillar polyps: high endothelial venules as participants of the polyp’s lymphoid tissue. Virchows Arch. 2011;459:65–71. https://doi.org/10.1007/s00428-011-1088-8.CrossRefPubMed

Min HJ, Kim KS. Lymphangiomatous polyp arising from the palatine tonsil. Ear Nose Throat J. 2021;100:NP154–5. https://doi.org/10.1177/0145561319863367.CrossRefPubMed

International Agency for Research on Cancer. WHO Global Cancer Observatory. Lyon: International Agency for Research on Cancer; 2020.

Shield KD, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi AK, Bray F, et al. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin. 2017;67:51–64. https://doi.org/10.3322/caac.21384.CrossRefPubMed

Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294–301. https://doi.org/10.1200/JCO.2011.36.4596.CrossRefPubMedPubMedCentral

10.

Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24–35.PubMedPubMedCentral

11.

Wotman M, Oh EJ, Ahn S, Kraus D, Costantino P, Tham T. HPV status in patients with nasopharyngeal carcinoma in the United States: a SEER database study. Am J Otolaryngol. 2019;40:705–10.PubMed

12.

Verma V, Simone CB, Lin C. Human papillomavirus and nasopharyngeal cancer. Head Neck. 2018;40:696–706. https://doi.org/10.1002/hed.24978.CrossRefPubMed

13.

Castellsagué X, Alemany L, Quer M, Halec G, Quirós B, Tous S, et al. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J Natl Cancer Inst. 2016;108:div403.

14.

Lam EWH, Chan JYW, Chan ABW, Ng CS, Lo STH, Lam VSC, et al. Prevalence, clinicopathological characteristics, and outcome of human papillomavirus-associated oropharyngeal cancer in Southern Chinese Patients. Cancer Epidemiol Biomark Prev. 2016;25:165–73. https://doi.org/10.1158/1055-9965.EPI-15-0869.CrossRef

15.

Shaikh MH, Khan AI, Sadat A, Chowdhury AH, Jinnah SA, Gopalan V, et al. Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh. BMC Cancer. 2017;17:792. https://doi.org/10.1186/s12885-017-3789-0.CrossRefPubMedPubMedCentral

16.

Lim MY, Dahlstrom KR, Sturgis EM, Li G. Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma. Head Neck. 2016;38:1139–44. https://doi.org/10.1002/hed.24429.CrossRefPubMed

17.

Augustin J, Mandavit M, Outh-Gauer S, Grard O, Gasne C, Lépine C, et al. HPV RNA CISH score identifies two prognostic groups in a p16 positive oropharyngeal squamous cell carcinoma population. Mod Pathol. 2018;31:1645–52.PubMed

18.

Drake VE, Fakhry C, Windon MJ, Stewart CM, Akst L, Hillel A, et al. Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer. Cancer. 2021;127:1029–38.PubMed

19.

Fakhry C, Waterboer T, Westra WH, Rooper LM, Windon M, Troy T, et al. Distinct biomarker and behavioral profiles of human papillomavirus-related oropharynx cancer patients by age. Oral Oncol. 2020;101:104522.PubMed

20.

Roberts S, Evans D, Mehanna H, Parish JL. Modelling human papillomavirus biology in oropharyngeal keratinocytes. Philos Trans R Soc B Biol Sci. 2019;374:20180289. https://doi.org/10.1098/rstb.2018.0289.CrossRef

21.

Westra WH. The morphologic profile of HPV-related head and neck squamous carcinoma: implications for diagnosis, prognosis, and clinical management. Head Neck Pathol. 2012;6:48–54. https://doi.org/10.1007/s12105-012-0371-6.CrossRefPubMedCentral

22.

Perry ME. The specialised structure of crypt epithelium in the human palatine tonsil and its functional significance. J Anat. 1994;185(Pt 1):111–27.PubMedPubMedCentral

23.

Kranjec C, Holleywood C, Libert D, Griffin H, Mahmood R, Isaacson E, et al. Modulation of basal cell fate during productive and transforming HPV-16 infection is mediated by progressive E6-driven depletion of Notch. J Pathol. 2017;242:448–62. https://doi.org/10.1002/path.4917.CrossRefPubMedPubMedCentral

24.

Lyford-Pike S, Peng S, Young GD, Taube JM, Westra WH, Akpeng B, et al. Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma. Cancer Res. 2013;73:1733–41.PubMedPubMedCentral

25.

Bishop JA, Westra WH. Ciliated HPV-related carcinoma: a well-differentiated form of head and neck carcinoma that can be mistaken for a benign cyst. Am J Surg Pathol. 2015;39:1591–5.PubMedPubMedCentral

26.

Alos L, Hakim S, Larque A-B, de la Oliva J, Rodriguez-Carunchio L, Caballero M, et al. p16 overexpression in high-grade neuroendocrine carcinomas of the head and neck: potential diagnostic pitfall with HPV-related carcinomas. Virchows Arch. 2016;469:277–84. https://doi.org/10.1007/s00428-016-1982-1.CrossRefPubMed

27.

Bates T, McQueen A, Iqbal MS, Kelly C, Robinson M. Small cell neuroendocrine carcinoma of the oropharynx harbouring oncogenic HPV-infection. Head Neck Pathol. 2014;8:127–31. https://doi.org/10.1007/s12105-013-0471-y.CrossRefPubMed

28.

Hojilla CV, Yu ES, Perez-Ordonez B. Human papillomavirus-associated poorly differentiated (small cell) neuroendocrine carcinoma of the oropharynx. Diagnos Histopathol. 2013;19:20–4.

29.

Bishop JA, Westra WH. Human papillomavirus-related small cell carcinoma of the oropharynx. Am J Surg Pathol. 2011;35:1679–84.PubMedPubMedCentral

30.

Kraft S, Faquin WC, Krane JF. HPV-associated Neuroendocrine carcinoma of the oropharynx. Am J Surg Pathol. 2012;36:321–30.PubMed

31.

Thompson ED, Stelow EB, Mills SE, Westra WH, Bishop JA. Large cell neuroendocrine carcinoma of the head and neck. Am J Surg Pathol. 2016;40:471–8.PubMedPubMedCentral

32.

D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944–56. https://doi.org/10.1056/nejmoa065497.CrossRefPubMed

33.

Würdemann N, Wagner S, Sharma SJ, Prigge E-S, Reuschenbach M, Gattenlöhner S, et al. Prognostic impact of AJCC/UICC 8th editon new staging rules in oropharyngeal squamous cell carcinoma. Front Oncol. 2017. https://doi.org/10.3389/fonc.2017.00129/full.CrossRefPubMedPubMedCentral

34.

Goldenberg D, Begum S, Westra WH, Khan Z, Sciubba J, Pai SI, et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck. 2008;30:898–903. https://doi.org/10.1002/hed.20796.CrossRefPubMed

35.

Yasui T, Morii E, Yamamoto Y, Yoshii T, Takenaka Y, Nakahara S, et al. Human papillomavirus and cystic node metastasis in oropharyngeal cancer and cancer of unknown primary origin. PLoS ONE. 2014;9:e95364. https://doi.org/10.1371/journal.pone.0095364.CrossRefPubMedPubMedCentral

36.

Morani AC, Eisbruch A, Carey TE, Hauff SJ, Walline HM, Mukherji SK. Intranodal cystic changes. J Comput Assist Tomogr. 2013;37:343–5.PubMedPubMedCentral

37.

An Y, Park HS, Kelly JR, Stahl JM, Yarbrough WG, Burtness BA, et al. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma. Cancer. 2017;123:2762–72.PubMed

38.

Day AT, Yang AM, Tanamal P, Blackwell J-M, Wang E, Sumer BD, et al. Extracapsular extension, pathologic node status, and adjuvant treatment in primary surgery patients with human papillomavirus-mediated oropharyngeal cancer: National hospital-based retrospective cohort analysis. Head Neck. 2021;43:3345–63.PubMed

39.

Martinez-Zapien D, Ruiz FX, Poirson J, Mitschler A, Ramirez J, Forster A, et al. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53. Nature. 2016;529:541–5.PubMedPubMedCentral

40.

Hoppe-Seyler K, Bossler F, Braun JA, Herrmann AL, Hoppe-Seyler F. The HPV E6/E7 oncogenes: key factors for viral carcinogenesis and therapeutic targets. Trends Microbiol. 2018;26:158–68.PubMed

41.

Augustin JG, Lepine C, Morini A, Brunet A, Veyer D, Brochard C, et al. HPV detection in head and neck squamous cell carcinomas: what is the issue? Front Oncol. 2020. https://doi.org/10.3389/fonc.2020.01751/full.CrossRefPubMedPubMedCentral

42.

Lewis JS, Beadle B, Bishop JA, Chernock RD, Colasacco C, Lacchetti C, et al. Human papillomavirus testing in head and neck carcinomas: guideline from the college of american pathologists. Arch Pathol Lab Med. 2018;142:559–97.PubMed

43.

McLaughlin-Drubin ME, Crum CP, Münger K. Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming. Proc Natl Acad Sci USA. 2011;108:2130–5. https://doi.org/10.1073/pnas.1009933108.CrossRefPubMedPubMedCentral

44.

Nauta IH, Rietbergen MM, van Bokhoven AAJD, Bloemena E, Lissenberg-Witte BI, Heideman DAM, et al. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing. Ann Oncol. 2018;29:1273–9.PubMed

45.

Mehanna H, Evans M, Beasley M, Chatterjee S, Dilkes M, Homer J, et al. Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130:S90–6.PubMedPubMedCentral

46.

Fakhry C, Lacchetti C, Perez-Ordonez B. Human papillomavirus testing in head and neck carcinomas: ASCO clinical practice guideline endorsement summary of the CAP guideline. J Oncol Pract. 2018;14:613–7. https://doi.org/10.1200/JOP.18.00433.CrossRefPubMed

47.

El-Naggar AK, Westra WH. p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck. 2012;34:459–61. https://doi.org/10.1002/hed.21974.CrossRefPubMed

48.

Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499:214–8.PubMedPubMedCentral

49.

Seiwert TY, Zuo Z, Keck MK, Khattri A, Pedamallu CS, Stricker T, et al. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin Cancer Res. 2015;21:632–41.PubMed

50.

Feldman R, Gatalica Z, Knezetic J, Reddy S, Nathan C-A, Javadi N, et al. Molecular profiling of head and neck squamous cell carcinoma. Head Neck. 2016;38(Suppl 1):E1625-1638.PubMed

51.

Misiukiewicz K, Gupta V, Miles BA, Bakst R, Genden E, Selkridge I, et al. Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: the Quarterback trial. Oral Oncol. 2019;95:170–7.PubMed

52.

Wang MB, Liu IY, Gornbein JA, Nguyen CT. HPV-positive oropharyngeal carcinoma. Otolaryngol Neck Surg. 2015;153:758–69. https://doi.org/10.1177/0194599815592157.CrossRef

53.

Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et al. Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:122–37.PubMed

54.

Lewis JS, Adelstein DJ, Agaimy A, Carlson DL, Faquin WC, Helliwell T, et al. Data set for the reporting of carcinomas of the nasopharynx and oropharynx: explanations and recommendations of the guidelines from the international collaboration on cancer reporting. Arch Pathol Lab Med. 2019;143:447–51.PubMed

55.

Howard J, Dwivedi RC, Masterson L, Kothari P, Quon H, Holsinger FC. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma. Cochrane Database Syst Rev. 2018. https://doi.org/10.1002/14651858.CD012939.pub2.CrossRefPubMedPubMedCentral

56.

Khariwala SS, Hatsukami D, Hecht SS. Tobacco carcinogen metabolites and DNA adducts as biomarkers in Head and Neck cancer: potential screening tools and prognostic indicators. Head Neck. 2012;34:441–7. https://doi.org/10.1002/hed.21705.CrossRefPubMed

57.

Seitz HK, Stickel F. Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol Chem. 2006. https://doi.org/10.1515/BC.2006.047/html.CrossRefPubMed

58.

Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer. 2007;7:599–612.PubMed

59.

Gormley M, Dudding T, Sanderson E, Martin RM, Thomas S, Tyrrell J, et al. A multivariable Mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancer. Nat Commun. 2020;11:6071.PubMedPubMedCentral

60.

Tramacere I, Negri E, Bagnardi V, Garavello W, Rota M, Scotti L, et al. A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 1: overall results and dose-risk relation. Oral Oncol. 2010;46:497–503.PubMed

61.

Kim HAJ, Zeng PYF, Shaikh MH, Mundi N, Ghasemi F, Di Gravio E, et al. All HPV-negative head and neck cancers are not the same: analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles. Oral Oncol. 2021;116:105260.PubMed

62.

Outh-Gauer S, Morini A, Tartour E, Lépine C, Jung AC, Badoual C. The microenvironment of head and neck cancers: papillomavirus involvement and potential impact of immunomodulatory treatments. Head Neck Pathol. 2020;14:330–40. https://doi.org/10.1007/s12105-020-01147-x.CrossRefPubMedPubMedCentral

63.

Bishop JA, Montgomery EA, Westra WH. Use of p40 and p63 immunohistochemistry and human papillomavirus testing as ancillary tools for the recognition of head and neck sarcomatoid carcinoma and its distinction from benign and malignant mesenchymal processes. Am J Surg Pathol. 2014;38:257–64.PubMedPubMedCentral

64.

Tse E, Kwong Y-L. NK/T-cell lymphomas. Best Pract Res Clin Haematol. 2019;32:253–61.PubMed

65.

Cone BM, Taweevisit M, Shenoda S, Sobol S, Schemankewitz E, Shehata BM. Pharyngeal hairy polyps: five new cases and review of the literature. Fetal Pediatr Pathol. 2012;31:184–9. https://doi.org/10.3109/15513815.2011.648722.CrossRefPubMed

66.

Melzer JM, Morgan A, Darrow D. Congenital choristoma (Hairy Polyp) of the Eustachian tube: surgical management of a rare clinical entity. Ear Nose Throat J. 2016;95:E43–5. https://doi.org/10.1177/014556131609500106.CrossRefPubMed

67.

Herrmann BW, Dehner LP, Lieu JEC. Congenital salivary gland anlage tumor: a case series and review of the literature. Int J Pediatr Otorhinolaryngol. 2005;69:149–56.PubMed

68.

Peters SM, Turk AT. Salivary gland anlage tumor: molecular profiling sheds light on a morphologic question. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127:e108–13.PubMed

69.

Lai Y, Li W, Zhai C, Song X, Yang J, Sun X, et al. Low-grade nasopharyngeal papillary adenocarcinoma: a review of 28 patients in a Single Institution. Cancer Manage Res. 2021;13:1271–8.

70.

Pineda-Daboin K, Neto A, Ochoa-Perez V, Luna MA. Nasopharyngeal adenocarcinomas: a clinicopathologic study of 44 cases including immunohistochemical features of 18 papillary phenotypes. Ann Diagn Pathol. 2006;10:215–21.PubMed

71.

Thompson LDR. Nasopharyngeal papillary adenocarcinoma. Ear Nose Throat J. 2017;96:456–7. https://doi.org/10.1177/014556131709601203.CrossRefPubMed

72.

Yu MC, Yuan J-M. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12:421–9.PubMed

73.

Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global cancer observatory: cancer today. Lyon: International Agency for Research on Cancer; 2020.

74.

Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, et al. Cancer incidence in Five Continents, vol. XI. Lyon: International Lyon; 2017.

75.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. https://doi.org/10.3322/caac.21492.CrossRefPubMed

76.

Huang WB, Chan JYW, Liu DL. Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: multicenter study from an endemic area in Southern China. Cancer. 2018;124:530–6. https://doi.org/10.1002/cncr.31031.CrossRefPubMed

77.

Augustin J, Outh-Gauer S, Mandavit M, Gasne C, Grard O, Denize T, et al. Evaluation of the efficacy of the 4 tests (p16 immunochemistry, polymerase chain reaction, DNA, and RNA in situ hybridization) to evaluate a human papillomavirus infection in head and neck cancers: a cohort of 348 French squamous cell carcinomas. Hum Pathol. 2018;78:63–71.PubMed

78.

Lin Z, Khong B, Kwok S, Cao H, West RB, Le Q-T, et al. Human papillomavirus 16 detected in nasopharyngeal carcinomas in white Americans but not in endemic Southern Chinese patients. Head Neck. 2014;36:709–14. https://doi.org/10.1002/hed.23362.CrossRefPubMed

79.

O’Sullivan B, Brierley JD, D’Cruz A, Fey M, Pollock RE, Vermorken J, et al. Nasopharynx. UICC Manual of Clinical Oncology. 9th ed. 2015. p. 512–23.

80.

Pan JJ, Ng WT, Zong JF, Chan LLK, O’Sullivan B, Lin SJ, et al. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer. 2016;122:546–58. https://doi.org/10.1002/cncr.29795.CrossRefPubMed

81.

Yang X-L, Wang Y, Liang S-B, He S-S, Chen D-M, Chen H-Y, et al. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers. BMC Cancer. 2018;18:606. https://doi.org/10.1186/s12885-018-4419-1.CrossRefPubMedPubMedCentral

82.

Chua DTT, Nicholls JM, Sham JST, Au GKH. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59:11–20.PubMed

Titel: Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Oropharynx and Nasopharynx
verfasst von: Cécile Badoual
Publikationsdatum: 21.03.2022
Verlag: Springer US
Erschienen in: Head and Neck Pathology / Ausgabe 1/2022
Elektronische ISSN: 1936-0568
DOI: https://doi.org/10.1007/s12105-022-01449-2

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Oropharynx and Nasopharynx

Abstract

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: The Neck and Lymph Nodes, Metastasis, and Melanocytic Tumors

Ossifying Fibroma of Non-odontogenic Origin: A Fibro-osseous Lesion in the Craniofacial Skeleton to be (Re-)considered

SALL-4 and Beta-Catenin Expression in Sinonasal Teratocarcinosarcoma

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Tumours of the Oral Cavity and Mobile Tongue

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Familial Tumor Syndromes

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren